Evidence Hub

Clinical Evaluation of a Time-Sequential Biphasic NMN–Resveratrol–Quercetin–Piperine NAD+ Supplement Targeting SIRT1 (BCLC™)

Nour-Eddine Ziraoui, S. Rossi, D. Volkov

Frontiers in Sustainable Development, 2026

Abstract

Background: Time-sequential biphasic NAD+ formulations are designed to solve the temporal mismatch, poor dissolution, and exposure instability that often limit conventional NMN combinations. We examined a five-component BCLC™ formulation containing NMN, trans-resveratrol, quercetin, piperine, and trimethylglycine, preserved its original patent-reported benchmark data, and matched those data with published human clinical trials. Methods: We retained the original formulation specifications, dissolution and stability results, and in-vitro SIRT1-related benchmarks reported in the source document, then searched PubMed, PubMed Central, and clinical-trial records through March 28, 2026 for adult interventional studies involving NMN, resveratrol, quercetin, or piperine that were relevant to NAD+, SIRT1, insulin sensitivity, oxidative stress, physical function, or bioavailability. Results: In the patent dataset, the leading embodiments achieved 4.1–5.5-fold SIRT1 pathway activation, 95.6–98.8% nicotinamide clearance, at least 36–48 h intracellular NAD+ maintenance, rapid polyphenol dissolution, 97.8–98.5% three-month retention, and material loss no higher than 3.5%. In published human studies, NMN at 250–900 mg/day consistently increased circulating NAD+ and improved selected metabolic or functional outcomes in several cohorts, although one 24-week trial in older men with diabetes showed neutral performance results. Resveratrol increased skeletal muscle SIRT1 or oxidative-stress…

How strong is the evidence?

Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free